+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific AI In Cancer Diagnostics Market Size, Share & Industry Trends Analysis Report By End-user (Hospital, Surgical Centers & Medical Institutes), By Component (Software Solutions, Hardware and Services), By Cancer Type, By Country and Growth Forecast, 2022 - 2028

  • PDF Icon

    Report

  • 86 Pages
  • November 2022
  • Region: Asia Pacific
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5709425
The Asia Pacific AI In Cancer Diagnostics Market should witness market growth of 29.6% CAGR during the forecast period (2022-2028).

Diagnosis of cancer starts with a complete body examination along with an entire medical report of the patient. As cancer is being detected, imaging procedures such as magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, fiber-optic endoscopy, and X-ray assist doctors to find the cancer location and size of the tumor.

In most cases to detect cancer, biopsy treatment is tested in humans in which a tissue specimen is detached from the diagnosis tumor and researched within a microscope to identify cancer cells in the body. As the testing of cancer comes out as positive, other tests are performed to deliver accurate cancer information. The following process is termed the staging where all the crucial information such as the spread of cancer in the body is acknowledged.

For example, a group of various researchers developed a methylation-based classifier that was originally designed to categorize subtypes of medulloblastomas. Later on, the project was expanded by the German-led team to include more than 100 extra cancers of the central nervous system. After the result of the reports were announced in March 2018, afterward, scientists introduced classifiers for the entire marketplace.

Head and neck cancer are the third most common cancer in India with about 52 067 mortalities and 77 000 diagnoses in 2012. Moreover, in China, caretaking of the cancer patient with non-disclosure of diagnosis to the patients is one of the most serious problems. As per the Law of the People’s Republic of China Medical professionals, or practitioners should open up with the truth to the patients and their caretakers. The law forces a legal authority on a medical specialist for a negative effect on the patient due to the resulting disclosure of diagnosis.

The China market dominated the Asia Pacific AI In Cancer Diagnostics Market by Country in 2021; thereby, achieving a market value of $36 million by 2028. The Japan market is registering CAGR of 28.8% during (2022-2028). Additionally, The India market would showcase a CAGR of 30.4% during (2022-2028).

Based on End-user, the market is segmented into Hospital, Surgical Centers & Medical Institutes and Others. Based on Component, the market is segmented into Software Solutions, Hardware and Services. Based on Cancer Type, the market is segmented into Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer & Cervical Cancer, Prostate & Colorectal Cancer and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.

Scope of the Study

By End-user

  • Hospital
  • Surgical Centers & Medical Institutes
  • Others

By Component

  • Software Solutions
  • Hardware
  • Services

By Cancer Type

  • Breast Cancer
  • Lung Cancer
  • Brain Tumor
  • Skin Cancer & Cervical Cancer
  • Prostate & Colorectal Cancer
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Key Market Players

List of Companies Profiled in the Report:

  • Microsoft Corporation
  • Flatiron Health
  • Paige AI, Inc.
  • PathAI, Inc.
  • Therapixel
  • Tempus, Inc.
  • SkinVision BV
  • Cancer Center Sp. z o.o.
  • Medial EarlySign
  • Kheiron Medical Technologies Limited

Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific AI In Cancer Diagnostics Market, by End-user
1.4.2 Asia Pacific AI In Cancer Diagnostics Market, by Component
1.4.3 Asia Pacific AI In Cancer Diagnostics Market, by Cancer Type
1.4.4 Asia Pacific AI In Cancer Diagnostics Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 The Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players
Chapter 4. Asia Pacific AI In Cancer Diagnostics Market by End-user
4.1 Asia Pacific Hospital Market by Country
4.2 Asia Pacific Surgical Centers & Medical Institutes Market by Country
4.3 Asia Pacific Others Market by Country
Chapter 5. Asia Pacific AI In Cancer Diagnostics Market by Component
5.1 Asia Pacific Software Solutions Market by Country
5.2 Asia Pacific Hardware Market by Country
5.3 Asia Pacific Services Market by Country
Chapter 6. Asia Pacific AI In Cancer Diagnostics Market by Cancer Type
6.1 Asia Pacific Breast Cancer Market by Country
6.2 Asia Pacific Lung Cancer Market by Country
6.3 Asia Pacific Brain Tumor Market by Country
6.4 Asia Pacific Skin Cancer & Cervical Cancer Market by Country
6.5 Asia Pacific Prostate & Colorectal Cancer Market by Country
6.6 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific AI In Cancer Diagnostics Market by Country
7.1 China AI In Cancer Diagnostics Market
7.1.1 China AI In Cancer Diagnostics Market by End-user
7.1.2 China AI In Cancer Diagnostics Market by Component
7.1.3 China AI In Cancer Diagnostics Market by Cancer Type
7.2 Japan AI In Cancer Diagnostics Market
7.2.1 Japan AI In Cancer Diagnostics Market by End-user
7.2.2 Japan AI In Cancer Diagnostics Market by Component
7.2.3 Japan AI In Cancer Diagnostics Market by Cancer Type
7.3 India AI In Cancer Diagnostics Market
7.3.1 India AI In Cancer Diagnostics Market by End-user
7.3.2 India AI In Cancer Diagnostics Market by Component
7.3.3 India AI In Cancer Diagnostics Market by Cancer Type
7.4 South Korea AI In Cancer Diagnostics Market
7.4.1 South Korea AI In Cancer Diagnostics Market by End-user
7.4.2 South Korea AI In Cancer Diagnostics Market by Component
7.4.3 South Korea AI In Cancer Diagnostics Market by Cancer Type
7.5 Singapore AI In Cancer Diagnostics Market
7.5.1 Singapore AI In Cancer Diagnostics Market by End-user
7.5.2 Singapore AI In Cancer Diagnostics Market by Component
7.5.3 Singapore AI In Cancer Diagnostics Market by Cancer Type
7.6 Malaysia AI In Cancer Diagnostics Market
7.6.1 Malaysia AI In Cancer Diagnostics Market by End-user
7.6.2 Malaysia AI In Cancer Diagnostics Market by Component
7.6.3 Malaysia AI In Cancer Diagnostics Market by Cancer Type
7.7 Rest of Asia Pacific AI In Cancer Diagnostics Market
7.7.1 Rest of Asia Pacific AI In Cancer Diagnostics Market by End-user
7.7.2 Rest of Asia Pacific AI In Cancer Diagnostics Market by Component
7.7.3 Rest of Asia Pacific AI In Cancer Diagnostics Market by Cancer Type
Chapter 8. Company Profiles
8.1 Microsoft Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 Flatiron Health (F. Hoffmann-La Roche Ltd.)
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent Strategies and Developments
8.2.5.1 Partnerships, Collaborations, and Agreements
8.3 Paige AI, Inc.
8.3.1 Company Overview
8.3.2 Recent Strategies and Developments
8.3.2.1 Partnerships, Collaborations, and Agreements
8.3.2.2 Product Launches and Product Expansions
8.4 PathAI, Inc.
8.4.1 Company Overview
8.4.2 Recent Strategies and Developments
8.4.2.1 Partnerships, Collaborations, and Agreements
8.4.2.2 Acquisition and Mergers
8.5 Therapixel
8.5.1 Company Overview
8.5.2 Recent Strategies and Developments
8.5.2.1 Product Launches and Product Expansions
8.6 Tempus, Inc.
8.6.1 Company Overview
8.6.2 Recent Strategies and Developments
8.6.2.1 Partnerships, Collaborations, and Agreements
8.7 SkinVision BV
8.7.1 Company Overview
8.8 Cancer Center Sp. z o.o.
8.8.1 Company Overview
8.9 Medial EarlySign
8.9.1 Company Overview
8.10. Kheiron Medical Technologies Limited
8.10.1 Company Overview
8.10.2 Recent Strategies and Developments
8.10.2.1 Partnerships, Collaborations, and Agreements

Companies Mentioned

  • Microsoft Corporation
  • Flatiron Health
  • Paige AI, Inc.
  • PathAI, Inc.
  • Therapixel
  • Tempus, Inc.
  • SkinVision BV
  • Cancer Center Sp. z o.o.
  • Medial EarlySign
  • Kheiron Medical Technologies Limited

Methodology

Loading
LOADING...